Q3 2023

Filed May 8, 2023 · 10-Q · 69 days after period end · 0001683168-23-002993

Q3 2023 · 10-Q

Revenue

$0.00

no prior Q3 2022 on file

Net Income

-$8.27K

no prior Q3 2022 on file

EPS Diluted

$0.00

no prior Q3 2022 on file

Gross Profit$0—

Operating Income

Same quarter

no prior Q3 2022 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Feb 28, 2023 · filed May 8, 2023 · 69 d after period end

Exousia Bio, Inc. · CIK 1939937 · Engraved from SEC EDGAR